MBBP Client MindChild Medical, Inc. Receives FDA Clearance of Fetal Heart Monitor

MindChild Medical, Inc., a client of MBBP, has received FDA clearance for its Pre-Marketing Notification (510(k)) for its MERIDIAN™ M110 non-invasive fetal heart monitor. The FDA clearance will enable MindChild to enter the U.S. market with MERIDIAN™. MindChild's MERIDIAN™ M110 Fetal Monitoring System is an intrapartum fetal monitor that externally measures and displays fetal heart …

Continue reading MBBP Client MindChild Medical, Inc. Receives FDA Clearance of Fetal Heart Monitor

FDA Clears MindChild Medical’s Fetal Monitor

In February we reported that MBBP client MindChild Medical Inc. had filed for a Pre-Marketing Notification Application (510(k)) with the U.S. Food and Drug Administration for its non-invasive fetal heart rate monitor, MERIDIAN™.  On September 25, MindChild announced that the FDA has cleared MERIDIAN™ and anticipates it entering the U.S. markets in the near future. Bill Edelman, CEO of …

Continue reading FDA Clears MindChild Medical’s Fetal Monitor